Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential benefits. Early findings suggest that this higher dosage may boost the drug's ability to manage blood glucose, potentially offering improved outcomes for individuals with diabetes. Further investigation is underway to fully explore the long-term impac